ARCHIVES

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Reagan Asks $955 Million fr NCI In FY 1983, Up $13 Million Over Current Level; PDQ Is Coming

February 12, 1982

The Varmus Era: Controversy Continues

January 6, 1995

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997